
Drugs ·
Historical estimates imply 86% to 93% attrition before approval. Our analysis of 33,667 registered trials separately measures early termination and reported stopping reasons.

Structures ·
Learn how to use Boltz-2 online: assemble protein, ligand, DNA, and RNA chains, choose MSA depth and sampling settings, then interpret structure, confidence, and affinity outputs.

Drugs ·
Compare rare, neurodegenerative, heart, and liver disease counts, and distinguish fatty-liver grades from fibrosis, cirrhosis, hepatitis C, and liver cancer stages.

Drugs ·
About 4,500 human genes are considered part of the druggable genome. A major analysis counted 4,479 drugged or druggable genes, equal to 22% of protein-coding genes.

Drugs ·
Current drug discovery statistics on FDA novel drug approvals, clinical success rates, development cost, biosimilars, cell and gene therapies, AAV products, and CRISPR trials.

Drugs ·
A US drug patent usually lasts 20 years from filing, not FDA approval. Actual market exclusivity before generic entry averages about 12 to 15 years.

Antibodies ·
The FDA had approved 169 antibody-based biologics by the end of 2025. The total includes 113 IgG-based antibodies, 15 bispecifics, 14 antibody-drug conjugates, and other antibody formats.

Drugs ·
Global medicine spending reached about 1.94 trillion US dollars in 2025. See current figures for pharmaceutical advertising, marketing, profit, lobbying, companies, and employment.

Drugs ·
A clinical trial can last from several months to several years. See FDA ranges and observed ClinicalTrials.gov durations for Phase 1, Phase 2, and Phase 3 trials.

Drugs ·
A successful new vaccine usually takes 10 to 15 years to develop. See how research, clinical trials, FDA review, cost, and the COVID-19, polio, mumps, MMR, and Ebola timelines compare.

Drugs ·
The WHO classified 268 antibiotics used in humans in 2025, including 50 on its Essential Medicines List. The exact total depends on whether the count covers active substances, products, or classes.

Drugs ·
There is no single worldwide count of medicines. DrugBank lists 4,815 approved drugs and 19,879 total drug entries, while the 2025 WHO Essential Medicines List contains 523 medicines.

Drugs ·
FDA data contain 26,715 active prescription and OTC drug product records as of July 2026. These represent 13,961 applications, 4,539 drug names, and 2,329 distinct nonblank ingredient entries.

Drugs ·
Drug development cost estimates range from 161 million to 4.54 billion US dollars. Recent transparent studies put the typical approved new drug near 700 million to 1.3 billion US dollars after failure and capital adjustments.

Drugs ·
AI drug discovery statistics in 2026 include more than 500 FDA submissions with AI components from 2016 to 2023, 75 AI-discovered molecules entered the clinic by 2023, 241 million AlphaFold DB predictions, and measurable virtual-screening and ADMET benchmarks.

Drugs ·
Drug discovery trends in 2026 include 46 FDA CDER novel approvals in 2025, 104 EMA human medicine recommendations, 218,766 interventional drug or biological studies in ClinicalTrials.gov, over 500 FDA submissions with AI components from 2016 to 2023, and strong growth in precision and modality-specific discovery.